Clinical Trials Logo

Clinical Trial Summary

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. The POI guideline development group of ESHRE recommends the following diagnostic criteria: oligo/ amenorrhea for at least 4 months and an elevated follicle stimulating hormone (FSH) level >25 mIU/mL on two occasion >4 weeks apart. Some clinicians and researchers proposed that POI was a progressive disease and there were three stages of POI: occult POI, biochemical POI, overt POI. However, there is lack of reliable indicators to assess the different stages of POI. The present study is to explore the change of menstruation condition, basal follicle-stimulating hormone, anti-müllerian hormone and antral follicle count during the development of POI, and whether those marks can assess the different stages of POI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03518944
Study type Observational [Patient Registry]
Source Nanfang Hospital of Southern Medical University
Contact Shiling Chen, M.D./Ph.D.
Phone +86-020-62787604
Email chensl_92@163.com
Status Recruiting
Phase
Start date July 1, 2017
Completion date July 1, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02871986 - Pubertal Induction in Individuals With Hypogonadism N/A
Recruiting NCT02322060 - In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency
Recruiting NCT06167135 - Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
Active, not recruiting NCT04675970 - Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
Completed NCT04943354 - Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure N/A
Recruiting NCT03518918 - Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
Recruiting NCT05021094 - Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction Phase 4
Active, not recruiting NCT02795000 - Development a Predictive Nomogram for Primary Ovarian Insufficiency
Suspended NCT03021915 - Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure N/A
Completed NCT01436513 - A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. Phase 1
Recruiting NCT06117982 - The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency Phase 2
Recruiting NCT02068976 - Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
Completed NCT01973075 - Genetic Etiology in Premature Ovarian Insufficiency N/A
Completed NCT03568708 - Primary Ovarian Insufficiency: Phenotype and Optimal Treatment Phase 3
Not yet recruiting NCT02757469 - Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure N/A
Completed NCT02091128 - Pregnancy Chances in Classic Galactosemia N/A
Terminated NCT00650754 - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility Phase 2/Phase 3
Recruiting NCT03496636 - Autologous Ovarian Tissue Transplantation N/A
Active, not recruiting NCT05737329 - Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency Phase 1/Phase 2
Withdrawn NCT02922348 - Hormone Replacement for Premature Ovarian Insufficiency Phase 3